Global Contact Us twitter LinkedIn gbt About Our Commitment Research Our MedicineInvestors & Media Careers OUR MEDICINE For patients and healthcare providers in the United States, you can learn more about Oxbryta by visiting the product website or downloading the full U.S. prescribing information. Visit Oxbryta.com To report an adverse event or if you have a product quality complaint regarding the use of Oxbryta, in the United States please call 1-833-GBT-4YOU (1-833-428-4968) or visit GBTMedInfo.com. gbt Copyright 2021 Global Blood Therapeutics, Inc. Privacy Policy Online Tracking Opt-Out Guide Terms Of Use Community Guidelines P-VOX-US-00501 ABOUT Our Company Leadership Board of Directors Contact Us CAREERS OUR COMMITMENT Patients & Advocacy GBT’s Supported Conferences COVID-19 Information and Resources Corporate Giving The GBT Foundation Expanded Access RESEARCH Sickle Cell Disease Pipeline Externally Sponsored Research (ESR) Partnerships Publications OUR MEDICINE INVESTORS & MEDIA Company Summary Media Resources Press Releases Events & Presentations Quarterly Results Analyst Coverage Stock Information SEC Filings Governance Investor FAQs This site uses cookies to give you the best online experience. Learn more, including how to disable certain cookies on our Privacy Page. Accept × The health and safety of patients, healthcare professionals and our employees is our highest priority. Learn more about our response to the COVID-19 pandemic, including the direct support we are providing to the sickle cell disease community. COVID-19 Information and Resources Close